Once-Daily Tobramycin Safe for Cystic Fibrosis (Reuters)


Reuters - Once-daily treatment with the
intravenous antibiotic tobramycin for lung flare-ups in
patients with cystic fibrosis appears to be as effective and
perhaps less toxic to the kidneys than treatment three times a
day, especially in children, British investigators report.

Read more...